PHARMA-X CONSULTANCY LTD

Active
Company number 07609132Private limited companyIncorporated 2011

Key figures

−£12,481-229.2%
Net assets 2025
-20 k-10 k010 k20 k20202021202320242025

Like most small UK companies, PHARMA-X CONSULTANCY LTD does not publish a profit and loss account in its latest accounts. The figures below come from the balance sheet.

Ratios

2025

Sector comparison

SIC 21100

Where the company stands among the 1,055 active companies whose first SIC code is 21100 (Manufacture of basic pharmaceutical products).

Net assets−£12,481
Lower than 80% · median £41,497
Total assets£65,358
Lower than 65% · median £308,978
Cash£1,285
Lower than 88% · median £135,555
Employees0
Lower than 65% · median 1
Company age15.6 years
Older than 69% · median 9.0 years

Positions are approximate. Figures come from each company's latest accounts; money and employee figures are compared only with companies that filed accounts in pounds for a period ending in the last two and a half years and are not dormant, so those groups are smaller than 1,055. The line on each bar marks the median.

Summary: PHARMA-X CONSULTANCY LTD

What kind of company is it?

PHARMA-X CONSULTANCY LTD is a private limited company registered with Companies House under company number 07609132. It was incorporated on 19 Apr 2011. Its status is active. The registered office is in St leonards on sea (TN38). Its nature of business (SIC 2007) is manufacture of basic pharmaceutical products (21100), wholesale of pharmaceutical goods (46460), other human health activities (86900).

How is the company doing financially?

The latest accounts in the database are for 2025 (period ending 31 Dec 2025); the company files small company accounts (filleted). Net assets were −£12,481, down 229.2% on the previous year. Cash at bank and in hand was £1,285. The company had an average of 0 employees. Figures are available for 5 financial years (2020–2025).

How does it compare with similar companies?

Compared with 1,055 active companies whose first SIC code is 21100: By net assets it ranks lower than 80% of them (median £41,497). By total assets it ranks lower than 65% of them (median £308,978). By cash it ranks lower than 88% of them (median £135,555). By number of employees it ranks lower than 65% of them (median 1). It is older than 69% of them (median age 9.0 years).

Who runs and controls the company?

The company has 1 current director. One person with significant control is registered.

When are its next filings due?

The next accounts are due by 30 Sep 2027. The next confirmation statement is due by 7 May 2027.

Control structure

Mr Harold Ian Dhanraj is the only person with significant control on record for this company; the PSC register shows no further links.

Filed accounts2020–2025
20202021202320242025
Cash at bank and in hand4,8624,6235,8532,5841,285
Total assets62,88262,33867,48575,08465,358
Total liabilities—————
Net assets / total equity8,1616,47014,3069,660-12,481
Average number of employees00000

A dash (—) means no accounts were filed for that year or the item is not in the accounts; 0 is a zero stated in the accounts. Small companies usually file only a balance sheet, so the profit and loss account is often missing.

History

9 events
  1. Financial year 2025 endedAccounts: net assets −£12.5k, 0 employees
  2. Financial year 2024 endedAccounts: net assets £9,660, 0 employees
  3. Financial year 2023 endedAccounts: net assets £14.3k, 0 employees
  4. Financial year 2021 endedAccounts: net assets £6,470, 0 employees
  5. Financial year 2020 endedAccounts: net assets £8,161, 0 employees
  6. Mr Harold Ian Dhanraj registered as a person with significant control
  7. Name changed to PHARMA-X CONSULTANCY LTDPreviously IAN DHANRAJ LTD
  8. Harold Ian DHANRAJ appointedDirector
Earlier events (1)
  1. Company incorporatedPrivate limited company

Dates as recorded at Companies House: incorporation, name changes, officer appointments and resignations, current persons with significant control, and the end of each financial year with figures in the database. Former persons with significant control are not listed.